Home
PRTG
PRTG News

Latest Portage Biotech Inc. (PRTG) News on June 6, 2025

MT Newswires

a month ago

Top Midday Gainers

MT Newswires

a month ago

Top Premarket Gainers

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

GlobeNewswire

a month ago

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Insider Stock Buying Reaches US$2.15m On Portage Biotech

Simply Wall St.

a month ago

Insider Stock Buying Reaches US$2.15m On Portage Biotech

MT Newswires

2 months ago

Top Midday Gainers

MT Newswires

2 months ago

Top Premarket Gainers

MT Newswires

2 months ago

Update: Portage Biotech Shares Jump Premarket After 'Promising' Preclinical Results in Mesothelioma

MT Newswires

2 months ago

Portage Reports 'Promising' Preclinical Results in Mesothelioma

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

GlobeNewswire

2 months ago

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

GlobeNewswire

3 months ago

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

GlobeNewswire

4 months ago

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

Portage Biotech Announces Completion of $2.15 Million Private Financing

GlobeNewswire

4 months ago

Portage Biotech Announces Completion of $2.15 Million Private Financing

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

GlobeNewswire

5 months ago

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

MT Newswires

6 months ago

Top Premarket Decliners

MT Newswires

6 months ago

Top Midday Gainers

MT Newswires

6 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MT Newswires

6 months ago

Portage Biotech Shares Soar Over 212% in Premarket Activity After Announcing Entering Letter of Intent With Immunova

MT Newswires

6 months ago

Top Premarket Gainers

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

GlobeNewswire

6 months ago

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter

GlobeNewswire

6 months ago

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

GlobeNewswire

6 months ago

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Portage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With Losses

Simply Wall St.

7 months ago

Portage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With Losses

MT Newswires

9 months ago

Top Premarket Gainers

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update

GlobeNewswire

9 months ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update

Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update

GlobeNewswire

10 months ago

Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update

Portage Biotech Announces 1-for-20 Reverse Stock Split

GlobeNewswire

10 months ago

Portage Biotech Announces 1-for-20 Reverse Stock Split

MT Newswires

a year ago

Converge Technology Solutions Rating, Price Target Left Unchanged by National Bank Following Deconsolidation of Portage CyberTech

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

GlobeNewswire

a year ago

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

GlobeNewswire

a year ago

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

Zacks Small Cap Research

a year ago

PRTG: Extending the Runway

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

GlobeNewswire

a year ago

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

Northann Corp.’s New 3-D Printing Ecosystem Products Receive “Best of” Innovation Awards at TISE2024

GlobeNewswire

a year ago

Northann Corp.’s New 3-D Printing Ecosystem Products Receive “Best of” Innovation Awards at TISE2024

Mullen Super-Crossover Five RS Spotlighted in AutoCar Article

NewMediaWire

a year ago

Mullen Super-Crossover Five RS Spotlighted in AutoCar Article

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Simply Wall St.

a year ago

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Bitcoin Depot to Deploy 940 Bitcoin ATMs at a National Convenience Store Retailer

GlobeNewswire

a year ago

Bitcoin Depot to Deploy 940 Bitcoin ATMs at a National Convenience Store Retailer

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

ACCESSWIRE

a year ago

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana

ACCESSWIRE

a year ago

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

Business Wire

a year ago

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination

GlobeNewswire

a year ago

Altitude Acquisition Corp. Announces Extension of Deadline to Complete Initial Business Combination

Akoustis Receives Wi-Fi 7 Design Win from Tier-1 Enterprise Wi-Fi AP Provider

GlobeNewswire

a year ago

Akoustis Receives Wi-Fi 7 Design Win from Tier-1 Enterprise Wi-Fi AP Provider

Zacks Small Cap Research

a year ago

PRTG: Bridging I-O: Working in Harmony with Checkpoints

DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business

GlobeNewswire

a year ago

DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business

Upexi CEO, Allan Marshall, to Present at the iAccess Alpha 2024 Buyside Best Ideas Summit on January 9th & 10th

ACCESSWIRE

a year ago

Upexi CEO, Allan Marshall, to Present at the iAccess Alpha 2024 Buyside Best Ideas Summit on January 9th & 10th

Portage Biotech Reports Business and Strategic Update

GlobeNewswire

a year ago

Portage Biotech Reports Business and Strategic Update

Perma-Pipe International Holdings announces acceptance into QatarEnergy’s Tawteen Program

Business Wire

a year ago

Perma-Pipe International Holdings announces acceptance into QatarEnergy’s Tawteen Program

Swvl Reports First Half 2023 Financial Results

GlobeNewswire

a year ago

Swvl Reports First Half 2023 Financial Results

Fujian Blue Hat Interactive Entertainment Technology First Half 2023 Earnings: US$0.36 loss per share (vs US$1.02 loss in 1H 2022)

Simply Wall St.

a year ago

Fujian Blue Hat Interactive Entertainment Technology First Half 2023 Earnings: US$0.36 loss per share (vs US$1.02 loss in 1H 2022)

Swvl Reports Receipt of Nasdaq Minimum Bid Price Notification

GlobeNewswire

a year ago

Swvl Reports Receipt of Nasdaq Minimum Bid Price Notification

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

GlobeNewswire

a year ago

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

Allspring Closed-End Funds Adopt Amended and Restated By-Laws

PR Newswire

a year ago

Allspring Closed-End Funds Adopt Amended and Restated By-Laws

Signet Jewelers Ltd CEO Virginia Drosos Sells 10,000 Shares

GuruFocus.com

a year ago

Signet Jewelers Ltd CEO Virginia Drosos Sells 10,000 Shares

Global Mofy Metaverse Limited together with China’s leading video platform Present AI-themed Short Film Series

GlobeNewswire

a year ago

Global Mofy Metaverse Limited together with China’s leading video platform Present AI-themed Short Film Series

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

GlobeNewswire

a year ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Perma-Pipe International Holdings (NASDAQ:PPIH) Is Experiencing Growth In Returns On Capital

Simply Wall St.

a year ago

Perma-Pipe International Holdings (NASDAQ:PPIH) Is Experiencing Growth In Returns On Capital

Is Genasys (NASDAQ:GNSS) In A Good Position To Invest In Growth?

Simply Wall St.

a year ago

Is Genasys (NASDAQ:GNSS) In A Good Position To Invest In Growth?

Is It Smart To Buy Hawthorn Bancshares, Inc. (NASDAQ:HWBK) Before It Goes Ex-Dividend?

Simply Wall St.

a year ago

Is It Smart To Buy Hawthorn Bancshares, Inc. (NASDAQ:HWBK) Before It Goes Ex-Dividend?

Genasys Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire

a year ago

Genasys Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2023 Financial Results

Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication

Exec Edge

a year ago

Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication

SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings

PR Newswire

a year ago

SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings

Global Mofy Metaverse Limited Receives "Most Valuable Investment Chinese Concept Stock" Award

GlobeNewswire

2 years ago

Global Mofy Metaverse Limited Receives "Most Valuable Investment Chinese Concept Stock" Award

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

PR Newswire

2 years ago

VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre

Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation

GlobeNewswire

2 years ago

Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation

Alliance Entertainment’s AMPED Distribution to Empower Vydia’s Expansion into Physical Distribution

GlobeNewswire

2 years ago

Alliance Entertainment’s AMPED Distribution to Empower Vydia’s Expansion into Physical Distribution

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

GlobeNewswire

2 years ago

Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

Grown Brilliance Integrates Katapult to Help Qualified Consumers Acquire High-Quality Diamond Jewelry

GlobeNewswire

2 years ago

Grown Brilliance Integrates Katapult to Help Qualified Consumers Acquire High-Quality Diamond Jewelry

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

GlobeNewswire

2 years ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

Cidara Therapeutics Named as a San Diego Metro Area Top Workplace

GlobeNewswire

2 years ago

Cidara Therapeutics Named as a San Diego Metro Area Top Workplace

VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript

Precision Optics Receives Initial Purchase Order Against $1.4 Million Development Program

PR Newswire

2 years ago

Precision Optics Receives Initial Purchase Order Against $1.4 Million Development Program

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript

Associated Press Finance

2 years ago

TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Business Wire

2 years ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

Investors Title Company Board Declares Special Cash Dividend and Regular Quarterly Cash Dividend

Business Wire

2 years ago

Investors Title Company Board Declares Special Cash Dividend and Regular Quarterly Cash Dividend

Share on Social Networks: